BIO-HYALUR 1% versus Protectalon 1.4% during phacoemulsification
In a randomized study of 140 patients, both OVDs produced comparable IOP, endothelial and visual outcomes through 90 days; no IOP spike of at least 30 mmHg occurred.
doi: 10.1007/s40123-026-01456-4